Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Mar;5(Suppl 1):S42-8.
doi: 10.1016/j.jceh.2014.11.006. Epub 2014 Dec 4.

Minimal hepatic encephalopathy impairs quality of life

Swastik Agrawal  1 , Sridharan Umapathy  1 , Radha K Dhiman  1
Affiliations
Review

Minimal hepatic encephalopathy impairs quality of life

Swastik Agrawal et al. J Clin Exp Hepatol. 2015 Mar.

Abstract

Minimal hepatic encephalopathy (MHE) is the mildest form of the spectrum of neurocognitive impairment in cirrhosis. It is a frequent occurrence in patients of cirrhosis and is detectable only by specialized neurocognitive testing. MHE is a clinically significant disorder which impairs daily functioning, driving performance, work capability and learning ability. It also predisposes to the development of overt hepatic encephalopathy, increased falls and increased mortality. This results in impaired quality of life for the patient as well as significant social and economic burden for health providers and care givers. Early detection and treatment of MHE with ammonia lowering therapy can reverse MHE and improve quality of life.

Keywords: CLDQ, Chronic Liver Disease Questionnaire; CTP, Child-Turcotte-Pugh; HE, Hepatic encephalopathy; HRQOL, Health related quality of life; MHE, Minimal hepatic encephalopathy; NHP, Nottingham Health Profile; SIP, Sickness Impact Profile; ammonia lowering therapy; cirrhosis; neurocognitive testing.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Clinical significance of minimal hepatic encephalopathy.
See this image and copyright information in PMC

References

    1. Seyan A.S., Hughes R.D., Shawcross D.L. Changing face of hepatic encephalopathy: role of inflammation and oxidative stress. World J Gastroenterol. 2010;16:3347–3357. - PMC - PubMed
    1. Dhiman R.K., Saraswat V., Duseja A., Chawla Y.K. MHE. Consensus statement of a working party of the indian national association for study of the liver. J Gastroenterol Hepatol. 2010;25:1029–1041. - PubMed
    1. Dhiman R.K., Chawla Y.K. Minimal hepatic encephalopathy. Indian J Gastroenterol. 2009;28:5–16. - PubMed
    1. Zeegen R., Drinkwater J.E., Dawson A.M. Method for measuring cerebral dysfunction in patients with liver disease. Br Med J. 1970;2:633–636. - PMC - PubMed
    1. Rikkers L., Jenko P., Rudman D., Freides D. Subclinical hepatic encephalopathy: detection, prevalence, and relationship to nitrogen metabolism. Gastroenterology. 1978;75:462–469. - PubMed